Pfizer buys cancer drug company Medivation for $14 billion in cash
August 22, 2016 at 06:46 AM EDT
Pfizer announced Monday it will acquire cancer drug company Medivation in a deal worth nearly $14 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.